SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 106.91 |
| Enterprise Value ($M) | 103.71 |
| Book Value ($M) | 5.47 |
| Book Value / Share | 0.40 |
| Price / Book | 19.55 |
| NCAV ($M) | -5.46 |
| NCAV / Share | -0.40 |
| Price / NCAV | -19.58 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.54 |
| Return on Assets (ROA) | 0.24 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.99 |
| Current Ratio | 0.99 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 19.70 |
| Assets | 30.63 |
| Liabilities | 25.16 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Tocqueville Asset Management L.p. | 4.40 | -11.05 | |
| 13G/A | West Elk Partners, LP | 6.49 | -19.28 | |
| 13D/A | New Enterprise Associates 14, L.P. | 12.60 | -94.10 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 4,567 | 27,878 | 16.38 | |
| 6,784 | 33,225 | 20.42 | |
| 15,089 | 80,854 | 18.66 | |
| 4,803 | 34,205 | 14.04 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CRDF – Cardiff Oncology, Inc. | CRIS – Curis, Inc. |
| CRVO – CervoMed Inc. | CSCI – COSCIENS Biopharma Inc. |
| CTXR – Citius Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io